Acción A287410 JEISYS MEDICAL INC.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Jeisys Medical Inc.

Acciones

A287410

KR7287410005

Precio de cierre Korea S.E.
Otros sitios de cotización
 00:00:00 05/07/2024 		Varia. Cinco días. Varia. 1 de enero.
12.890 KRW 0,00 % Gráfico intradía de Jeisys Medical Inc. +0,16 % +22,88 %
11/04 AVAVA anuncia una asociación de distribución exclusiva con Jeisys Medical Inc. para Corea y Japón CI
2023 Jeisys Medical Inc. (KOSDAQ:A287410) anuncia una recompra de acciones por valor de 10.000 millones de KRW. CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
AVAVA, Inc. announced that it has received $35 million in funding from Jeisys Medical Inc., Catalio Capital Management, LP and other investors
Syracuse Subco, Inc proposed to acquire an additional 72.04% stake in Jeisys Medical Inc. for approximately KRW 720 billion.
An undisclosed buyer agreed to acquire 23.45% stake in Jeisys Medical Inc. from Kang, Donghwan.
AVAVA Announces Exclusive Distribution Partnership with Jeisys Medical Inc. for Korea and Japan
AVAVA, Inc. announced that it expects to receive $14.999999 million in funding from Jeisys Medical Inc.
Tranche Update on Jeisys Medical Inc.'s Equity Buyback Plan announced on May 15, 2023.
Tranche Update on Jeisys Medical Inc.'s Equity Buyback Plan announced on May 15, 2023.
Jeisys Medical Inc.'s Equity Buyback announced on May 15, 2023, has closed with 1,075,838 shares, representing 1.42% for KRW 10,000.85 million.
Imeik Technology Wins Exclusive Rights to Distribute Jeisys’ Aesthetic Equipment in China
Tranche Update on Jeisys Medical Inc.'s Equity Buyback Plan announced on May 15, 2023.
Jeisys Medical Inc. announces an Equity Buyback.
Jeisys Medical Inc. authorizes a Buyback Plan.
Jeisys Medical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Cynosure KK Enters into Distribution Partnership with Jeisys Medical KK in Japan
Jeisys Medical Inc.(KOSDAQ:A287410) added to S&P Global BMI Index
SACCI Bio Co., Ltd. announced that it expects to receive KRW 2.85 billion in funding from Jeisys Medical Inc.
Jeisys Medical Inc. completed the acquisition of Yuanta 3 SPECIAL PURPOSE ACQUISITION CO., LTD. from Alliance Capital Partners Co., Ltd. and others in a reverse merger transaction.
Jeisys Medical Inc. signed a contract to acquire Yuanta 3 SPECIAL PURPOSE ACQUISITION CO., LTD. from Alliance Capital Partners Co., Ltd. and others for approximately KRW 300 billion in a reverse merger transaction.
Jeisys Medical Inc. announced that it has received KRW 4.00043853 billion in funding from BNH Investment LLC, DAYLI Partners Co., Ltd., LSK Investment
Jeisys Medical Inc. announced that it expects to receive KRW 4.00043853 billion in funding from BNH Investment LLC, DAYLI Partners, LSK Investment
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción A287410
  4. Noticias Jeisys Medical Inc.
  5. Otros idiomas